X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3669) 3669
Publication (181) 181
Book Review (70) 70
Newsletter (41) 41
Book Chapter (22) 22
Conference Proceeding (6) 6
Newspaper Article (6) 6
Magazine Article (3) 3
Book / eBook (2) 2
Journal / eJournal (2) 2
Dissertation (1) 1
Paper (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pamidronate (2736) 2736
humans (2441) 2441
female (1581) 1581
male (1357) 1357
diphosphonates - therapeutic use (1273) 1273
bisphosphonates (1205) 1205
index medicus (1006) 1006
middle aged (853) 853
zoledronic acid (750) 750
aged (692) 692
oncology (668) 668
adult (663) 663
osteoporosis (649) 649
diphosphonates - administration & dosage (606) 606
endocrinology & metabolism (552) 552
bone neoplasms - secondary (533) 533
diphosphonates - adverse effects (514) 514
bone density conservation agents - therapeutic use (490) 490
bisphosphonate (454) 454
treatment outcome (436) 436
double-blind (435) 435
child (432) 432
alendronate (426) 426
children (420) 420
intravenous pamidronate (415) 415
animals (393) 393
bone neoplasms - drug therapy (385) 385
breast-cancer (372) 372
bone (370) 370
osteogenesis imperfecta (369) 369
therapy (368) 368
adolescent (350) 350
diphosphonates - pharmacology (343) 343
bone density - drug effects (332) 332
pediatrics (329) 329
cancer (323) 323
bone metastases (315) 315
bones (315) 315
care and treatment (310) 310
rheumatology (300) 300
diphosphonates (299) 299
medicine, general & internal (290) 290
hypercalcemia (286) 286
infusions, intravenous (267) 267
orthopedics (265) 265
aged, 80 and over (264) 264
bone density conservation agents - adverse effects (258) 258
multiple-myeloma (258) 258
bone density conservation agents - administration & dosage (252) 252
fractures (251) 251
disodium pamidronate (250) 250
skeletal complications (248) 248
medicine & public health (246) 246
clodronate (241) 241
disease (240) 240
bone density (236) 236
hypercalcemia - drug therapy (235) 235
breast neoplasms - pathology (234) 234
child, preschool (231) 231
imidazoles - therapeutic use (226) 226
breast cancer (224) 224
pain (223) 223
retrospective studies (220) 220
hypercalcemia - etiology (218) 218
efficacy (217) 217
surgery (209) 209
drug therapy (208) 208
osteoporosis - drug therapy (197) 197
risk factors (195) 195
prevention (194) 194
research (194) 194
follow-up studies (190) 190
health aspects (189) 189
osteonecrosis (187) 187
time factors (187) 187
pharmacology & pharmacy (185) 185
metastasis (183) 183
osteogenesis imperfecta - drug therapy (178) 178
density (177) 177
multiple myeloma (176) 176
bone mineral density (173) 173
radiography (172) 172
rats (171) 171
in-vitro (168) 168
analysis (166) 166
bone-mineral density (166) 166
administration, oral (165) 165
adolescents (163) 163
antineoplastic agents - therapeutic use (155) 155
dentistry, oral surgery & medicine (155) 155
women (153) 153
multiple myeloma - drug therapy (152) 152
resorption (152) 152
prospective studies (151) 151
phosphonates (149) 149
breast neoplasms - drug therapy (147) 147
dose-response relationship, drug (147) 147
drug administration schedule (146) 146
pamidronate disodium (146) 146
mineral density (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3494) 3494
German (76) 76
French (71) 71
Spanish (54) 54
Japanese (16) 16
Korean (15) 15
Portuguese (12) 12
Czech (5) 5
Turkish (5) 5
Italian (4) 4
Persian (4) 4
Polish (4) 4
Chinese (2) 2
Croatian (1) 1
Dutch (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 02/1982, Volume 12, Issue 1, pp. 29 - 35
Journal Article
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 11/1982, Volume 70, Issue 5, pp. 927 - 933
The bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl(2)MDP) effectively inhibit the... 
Dose-Response Relationship, Drug | Bone Resorption - drug effects | Cell Survival - drug effects | Macrophages - metabolism | Animals | Calcium - metabolism | Rats | Pamidronate | Kinetics | Rats, Inbred Strains | Binding Sites - drug effects | Diphosphonates - pharmacology
Journal Article
Calcified tissue international, ISSN 0171-967X, 05/1983, Volume 35, Issue 3, p. 357
The effects of 1.5-2 years oral administration of disodium (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on bone metabolism were studied in male and... 
Bone Resorption - drug effects | Bone Development - drug effects | Administration, Oral | Anthropometry | Rats | Male | Pamidronate | Diphosphonates - administration & dosage | Calcium - urine | Rats, Inbred Strains | Bone and Bones - anatomy & histology | Hydroxyproline - urine | Animals | Phosphates - urine | Female | Diphosphonates - pharmacology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.